TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/23 17:24 | 11/10/23 | ZNTL | Zentalis Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Johnson David Michael | NY | D | P | 168 | 9.88 | 0 | 17 | 13 | 144 | D | ||||||||||||||||
11/9/23 17:02 | 11/7/23 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Johnson David Michael | MA | D | P.m | 1,435 | 7.19 | 0 | 200 | 88 | 425 | M | |||||||||||||||
10/5/23 19:56 | 10/3/23 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Johnson David Michael | MA | D | P.m | 168 | 8.38 | 0 | 20 | 10 | 226 | D | |||||||||||||||
1/9/23 17:55 | 1/5/23 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Johnson David Michael | MA | D | P.m | 21 | 10.41 | 0 | 2 | 6 | 36 | I | |||||||||||||||
12/30/22 19:01 | 12/28/22 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Johnson David Michael | MA | D | P | 39 | 9.75 | 0 | 4 | 13 | 34 | I | |||||||||||||||
12/15/22 18:15 | 12/1/22 | AURA | Aura Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Johnson David Michael | MA | D | P | 124 | 12.37 | 0 | 10 | 50 | 30 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |